Favorable policies support biopharmaceutical stocks
Updated: 2013-02-08 13:58
(China Daily)
|
|||||||||||
China's encouraging policies for the biological industry are supporting the biopharmaceutical sector's share prices, industry observers said.
The National Development and Reform Commission, China's top economic planner, issued its 12th Five-Year Development Plan for the Biological Industry early last month, showing that the biological pharmaceutical sector is one of the seven key industries that China will support by 2020.
The plan stipulates that the annual growth of the sector should be 20 percent in the coming three years. The average increase in the biopharmaceutical sector's stock prices was estimated at 2 percent on the Shanghai Stock Exchange last month.
Related Stories
China gets WHO collaborating center for biological products 2013-01-18 14:11
High-end biological industry project to settle in Dalian 2012-12-18 17:27
Biological industry plans to be issued in November 2012-10-26 11:21
Project toward producing biological pharmacy 2012-09-26 10:09
Biological industry development plan completed 2012-02-14 11:23
Today's Top News
Police continue manhunt for 2nd bombing suspect
H7N9 flu transmission studied
8% growth predicted for Q2
Nuke reactor gets foreign contract
First couple on Time's list of most influential
'Green' awareness levels drop in Beijing
Palace Museum spruces up
Trading channels 'need to broaden'
Hot Topics
Lunar probe , China growth forecasts, Emission rules get tougher, China seen through 'colored lens', International board,
Editor's Picks
Liaoning: China's oceangoing giant |
Poultry industry under pressure |
'Spring' in the air for NGOs? |
Boy set to drive Chinese golf |
Latest technology gets people talking |
Firms crave cyber connection |